Research on neuroinflammatory processes has revolutionized our understanding of the pathophysiology underlying a range of neuropsychiatric and neurological ...

Damona Pharmaceuticals Inc. has obtained IND clearance from the FDA for DPX-101 for the treatment of cognitive deficits in brain disorders, including major depressive disorder. The company plans to ...

Attention-deficit hyperactivity disorder, or ADHD in short, is a long-term condition that includes a combination of different ...

According to new research, cognitive impairments in psychotic disorders, such as schizophrenia and bipolar disorder, are linked to brain network organization. This link between cognition and brain ...

Recent research published in the Journal of Psychiatric Research indicates that specific clusters of depressive symptoms are linked to distinct biological inflammation markers and cognitive deficits.

Big Health Inc, along with paid academic investigators, reports higher remission rates and lower anxiety symptom scores with ...

Prescription stimulants, such as Ritalin and Adderall, are widely used to treat attention deficit hyperactivity disorder ...

Mill Valley, CA – March 25, 2025 – The SynGAP Research Fund (SRF) dba Cure SYNGAP1 501(c)(3) announced a $130,000 grant to Dr. Vikaas Sohal at The Regents of The University of California, San ...

To understand iclepertin's safety and efficacy, researchers pooled phase 3 trial data, focusing on cognition in CIAS patients.